M&A Deal Summary |
|
|---|---|
| Date | 2011-04-04 |
| Target | TransMolecular |
| Sector | Life Science |
| Buyer(s) | Morphotek |
| Sellers(s) |
Greer Capital Advisors
Easton Capital Investment Group |
| Deal Type | Add-on Acquisition |
SEARCH BY
Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2011 M&A | 1 of 1 |
| Category | Private Equity Firm |
|---|---|
| Founded | 2002 |
| Size | Small |
| Type | Sector Focused |
Greer Capital Advisors (GCA) is a specialized, heathcare focused private equity firm that targets investments in Alabama based companies. Within healthcare, GCA looks for companies in the pharmaceutical, biotechnology, medical device, and diagnostics industries. GCA prefers early and growth stage investments and generally seeks to invest between $1 to $2 million per transaction. Greer Capital Advisors was formed in 2002 and is based in Birmingham, Alabama.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 13 |
| Sector: Life Science M&A | 6 of 10 |
| Type: Add-on Acquisition M&A Deals | 5 of 10 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 8 of 13 |
| Year: 2011 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-04-01 |
Tranzyme
Durham, North Carolina, United States Tranzyme Pharma is a clinical-stage company developing novel small molecule therapeutics for the treatment of gastrointestinal (GI) and metabolic diseases. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-09-05 |
Halo Monitoring
Huntsville, Alabama, United States Halo Monitoring is an ?aging in place technology? company. Halo?s product-service offering, myHalo, provides seniors, caregivers, and their families the most accurate and easy to use fall monitoring system and alert system on the market. Unlike manually activated alarm systems ('panic buttons'), which have been proven ineffective, myHalo uses proprietary motion signal processing technology and a 24/7 call center to automatically detect falls and ensure that fallen seniors can receive assistance when needed. |
Sell | - |
| Category | Venture Capital Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 200M USD |
| Size | Small |
| Type | Sector Focused |
Easton Capital Investment Group is a private investment firm that targets early-stage venture capital to later-stage growth capital investments. Easton will consider opportunities across a range of industries but generally invests in the healthcare industry, including biopharmaceuticals, drug delivery, medical devices, and healthcare services. Easton looks to commit $0.50 to $10 million per transaction. Easton Capital was formed in 2000 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 15 of 21 |
| Sector: Life Science M&A | 6 of 10 |
| Type: Add-on Acquisition M&A Deals | 9 of 9 |
| State: Massachusetts M&A | 2 of 4 |
| Country: United States M&A | 15 of 21 |
| Year: 2011 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-02-09 |
PlaySpan
Santa Clara, California, United States PlaySpan is the game industry's first publisher-sponsored in-game commerce network. PlaySpan's in-game search, commerce and micropayment technologies enables game publishers and developers to generate new revenues, acquire new users and extend the loyalty of existing users. PlaySpan is based in Silicon Valley. |
Sell | $190M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-05-17 |
Resolve Therapeutics
Kirkland, Washington, United States Resolve Therapeutics is a private biotechnology company that is dedicated to the goal of improving the lives of patients suffering from lupus. |
Buy | - |
